Susquehanna International Group’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $457K | Sell |
46,015
-122,973
| -73% | -$1.22M | ﹤0.01% | 4448 |
|
2025
Q1 | $1.6M | Sell |
168,988
-112,314
| -40% | -$1.07M | ﹤0.01% | 2599 |
|
2024
Q4 | $3.88M | Buy |
281,302
+157,890
| +128% | +$2.18M | ﹤0.01% | 1274 |
|
2024
Q3 | $1.88M | Buy |
123,412
+82,915
| +205% | +$1.26M | ﹤0.01% | 1909 |
|
2024
Q2 | $193K | Sell |
40,497
-275,763
| -87% | -$1.32M | ﹤0.01% | 4765 |
|
2024
Q1 | $2.15M | Buy |
316,260
+167,145
| +112% | +$1.13M | ﹤0.01% | 1733 |
|
2023
Q4 | $729K | Buy |
149,115
+19,840
| +15% | +$97K | ﹤0.01% | 3319 |
|
2023
Q3 | $442K | Buy |
129,275
+80,640
| +166% | +$276K | ﹤0.01% | 3585 |
|
2023
Q2 | $232K | Buy |
48,635
+14,117
| +41% | +$67.5K | ﹤0.01% | 4502 |
|
2023
Q1 | $146K | Sell |
34,518
-94,552
| -73% | -$399K | ﹤0.01% | 5057 |
|
2022
Q4 | $498K | Sell |
129,070
-16,361
| -11% | -$63.2K | ﹤0.01% | 3232 |
|
2022
Q3 | $873K | Sell |
145,431
-24,206
| -14% | -$145K | ﹤0.01% | 2726 |
|
2022
Q2 | $592K | Buy |
169,637
+11,175
| +7% | +$39K | ﹤0.01% | 3127 |
|
2022
Q1 | $544K | Sell |
158,462
-56,139
| -26% | -$193K | ﹤0.01% | 3602 |
|
2021
Q4 | $629K | Sell |
214,601
-23,764
| -10% | -$69.7K | ﹤0.01% | 3472 |
|
2021
Q3 | $958K | Sell |
238,365
-42,580
| -15% | -$171K | ﹤0.01% | 2814 |
|
2021
Q2 | $1.44M | Buy |
280,945
+72,719
| +35% | +$373K | ﹤0.01% | 2481 |
|
2021
Q1 | $974K | Buy |
208,226
+26,473
| +15% | +$124K | ﹤0.01% | 3037 |
|
2020
Q4 | $623K | Sell |
181,753
-102,483
| -36% | -$351K | ﹤0.01% | 3159 |
|
2020
Q3 | $1.49M | Buy |
284,236
+165,414
| +139% | +$868K | ﹤0.01% | 1725 |
|
2020
Q2 | $547K | Buy |
+118,822
| New | +$547K | ﹤0.01% | 2833 |
|
2017
Q1 | – | Sell |
-1,432
| Closed | -$38K | – | 3356 |
|
2016
Q4 | $38K | Buy |
+1,432
| New | +$38K | ﹤0.01% | 4009 |
|
2016
Q1 | – | Sell |
-1,570
| Closed | -$48K | – | 3884 |
|
2015
Q4 | $48K | Buy |
+1,570
| New | +$48K | ﹤0.01% | 4054 |
|